Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
11.87
+0.03 (0.25%)
At close: Jul 2, 2026, 4:00 PM EDT
11.95
+0.08 (0.67%)
After-hours: Jul 2, 2026, 7:27 PM EDT
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $3.97 billion as of July 2, 2026. Its market cap has decreased by -26.06% in one year.
Market Cap
3.97B
Enterprise Value
4.31B
1-Year Change
-26.06%
Ranking
Category
Stock Price
$11.87
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $3.97B, an increase of 3,346.52%. That is a compound annual growth rate of 50.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 3.97B | 57.01% |
| Dec 31, 2025 | 2.53B | -50.36% |
| Dec 31, 2024 | 5.10B | 129.18% |
| Dec 29, 2023 | 2.22B | 42.30% |
| Dec 30, 2022 | 1.56B | -2.70% |
| Dec 31, 2021 | 1.61B | 96.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viking Therapeutics | 4.35B |
| Tango Therapeutics | 4.26B |
| Edgewise Therapeutics | 4.26B |
| Denali Therapeutics | 4.10B |
| NewAmsterdam Pharma Company | 4.07B |
| Relay Therapeutics | 4.06B |
| Catalyst Pharmaceuticals | 3.85B |
| Arcus Biosciences | 3.81B |